TipRanks
Impact BioMedical, Inc. (IBO)
:IBO
US Market
IBO
Impact BioMedical, Inc.
RESEARCH TOOLSreports

Impact BioMedical, Inc. (IBO) Ratios

103 Followers

Impact BioMedical, Inc. Ratios

IBO's free cash flow for Q2 2026 was C$0.67. For the 2026 fiscal year, IBO's free cash flow was decreased by C$ and operating cash flow was C$-234.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.16 0.35 0.25 0.03 0.01
Quick Ratio
 0.13 0.30 0.25 0.03 0.01
Cash Ratio
 <0.01 <0.01 0.20 <0.01 <0.01
Solvency Ratio
 0.71 -5.78 -0.09 -0.26 -0.43
Operating Cash Flow Ratio
 -0.25 -1.63 -0.58 -0.22 -0.21
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -0.63 -0.24 -0.22
Net Current Asset Value
C$ -2.41M$ -1.44M$ -10.61M$ -16.04K$ -13.71K
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.44 0.27 0.21
Debt-to-Equity Ratio
 0.00 0.00 2.08 0.48 0.34
Debt-to-Capital Ratio
 0.00 0.00 0.68 0.32 0.25
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.56 1.38 4.76 1.77 1.57
Debt Service Coverage Ratio
 8.32 -12.52 -0.12 -0.33 -0.29
Interest Coverage Ratio
 -19.45 -5.38 3.27 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.15 <0.01 <0.01
Interest Debt Per Share
 <0.01 0.03 0.22 0.20 0.14
Net Debt to EBITDA
 0.02 <0.01 -6.43 -3.00 -4.36
Profitability Margins
Gross Profit Margin
-1111.43%-1225.00%100.00%0.00%100.00%
EBIT Margin
-4411.43%-42678.13%-80.76%0.00%-6808.00%
EBITDA Margin
-1145.71%-39100.00%-66.03%0.00%-4581.33%
Operating Profit Margin
-14562.86%-13343.75%23.67%0.00%-6808.00%
Pretax Profit Margin
-5154.29%-45156.25%-88.01%0.00%-15752.00%
Net Profit Margin
2254.29%-36993.75%-88.01%0.00%-14102.00%
Continuous Operations Profit Margin
2217.14%-37093.75%-88.01%0.00%-14510.00%
Net Income Per EBT
-43.74%81.92%100.00%98.39%89.53%
EBT Per EBIT
35.39%338.41%-371.89%109.41%231.37%
Return on Assets (ROA)
4.71%-68.01%-7.03%-9.71%-15.16%
Return on Equity (ROE)
13.70%-93.89%-33.47%-17.19%-23.86%
Return on Capital Employed (ROCE)
-34.67%-26.29%3.65%-12.79%-9.48%
Return on Invested Capital (ROIC)
14.91%-21.59%1.98%-9.24%-8.00%
Return on Tangible Assets
246.56%-2880.29%-57.44%-700.48%-514.67%
Earnings Yield
1.24%-74.30%-2.35%-0.02%-0.03%
Efficiency Ratios
Receivables Turnover
 0.18 0.16 8.80 0.00 0.00
Payables Turnover
 0.91 1.22 1.57 0.00 0.00
Inventory Turnover
 6.84 6.73 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 95.28 0.00 0.18
Asset Turnover
 <0.01 <0.01 0.08 0.00 <0.01
Working Capital Turnover Ratio
 -0.02 >-0.01 -0.16 0.00 >-0.01
Cash Conversion Cycle
 1.71K 2.07K -191.11 0.00 0.00
Days of Sales Outstanding
 2.05K 2.32K 41.46 0.00 0.00
Days of Inventory Outstanding
 53.37 54.23 0.00 0.00 0.00
Days of Payables Outstanding
 402.02 298.71 232.57 0.00 0.00
Operating Cycle
 2.11K 2.37K 41.46 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.06 -0.13 -0.05 -0.03
Free Cash Flow Per Share
 >-0.01 -0.06 -0.13 -0.05 -0.04
CapEx Per Share
 0.00 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.12
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -158.39 -8.12
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -158.39 -8.12
Operating Cash Flow Coverage Ratio
 0.00 0.00 -0.63 -0.24 -0.22
Operating Cash Flow to Sales Ratio
 -14.51 -59.06 -3.48 0.00 -44.84
Free Cash Flow Yield
-0.80%-11.86%-9.31%-0.01%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -6.05 -1.33 -210.14 -5.40K -3.88K
Price-to-Sales (P/S) Ratio
 1.82K 497.91 37.38 0.00 547.75K
Price-to-Book (P/B) Ratio
 5.91 1.26 14.22 928.01 926.61
Price-to-Free Cash Flow (P/FCF) Ratio
 -125.23 -8.43 -10.74 -8.16K -10.88K
Price-to-Operating Cash Flow Ratio
 -125.23 -8.43 -10.74 -8.21K -12.22K
Price-to-Earnings Growth (PEG) Ratio
 -0.03 >-0.01 2.33 192.79 -8.82
Price-to-Fair Value
 5.91 1.26 14.22 928.01 926.61
Enterprise Value Multiple
 -158.61 -1.27 -63.04 -5.82K -11.96K
Enterprise Value
 63.60M 15.93M 67.42M 23.42M 27.40M
EV to EBITDA
 -158.61 -1.27 -63.04 -5.82K -11.96K
EV to Sales
 1.82K 497.81 41.62 0.00 547.95K
EV to Free Cash Flow
 -125.21 -8.43 -11.96 -8.16K -10.88K
EV to Operating Cash Flow
 -125.21 -8.43 -11.96 -8.21K -12.22K
Tangible Book Value Per Share
 -0.02 -0.05 -0.25 -0.26 -0.18
Shareholders’ Equity Per Share
 0.10 0.40 0.10 0.42 0.42
Tax and Other Ratios
Effective Tax Rate
 1.43 0.18 -0.02 0.00 -0.08
Revenue Per Share
 <0.01 <0.01 0.04 0.00 <0.01
Net Income Per Share
 <0.01 -0.38 -0.03 -0.07 -0.10
Tax Burden
 -0.44 0.82 1.00 0.98 0.90
Interest Burden
 1.17 1.06 1.09 1.09 2.31
Research & Development to Revenue
 8.11 10.63 0.04 0.00 24.52
SG&A to Revenue
 84.74 61.75 0.44 0.00 15.80
Stock-Based Compensation to Revenue
 0.37 0.41 0.00 0.00 0.00
Income Quality
 -0.04 0.16 0.16 0.66 0.32